AXL and breast neoplasm: Axl is overexpressed in several drug-resistant cancer cell lines, such as nilotinib-resistant myeloid leukemia cells [160], lapatinib-resistant HER-2 positive breast tumor cells [161] and cisplatin-resistant ovarian tumors [162], suggesting that Axl may be involved in the development of QT-resistance.